ロード中...
Sequential Therapy with Nivolumab Followed by Ipilimumab Induces Complete Response in Metastatic Melanoma of the Lung but with Severe Hepatotoxicities
Since nivolumab significantly prolongs survival in patients with metastatic melanoma, the number of patients administered nivolumab is increasing, but only 30–40% of patients who received nivolumab monotherapy experienced objective tumor regression. Therefore, enhancing its anti-tumor immune respons...
保存先:
| 出版年: | Case Rep Oncol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
S. Karger AG
2016
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5118831/ https://ncbi.nlm.nih.gov/pubmed/27920696 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000450974 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|